The alternatively spliced αeC domain of human fibrinogen-420 is a novel ligand for leukocyte integrins αMβ2 and αXβ2

Blood

Volumn 98, Issue 8, 2001, Pages 2448-2455

  Lishko, Valeryi K ^a,b   Yakubenko, Valentin P ^a,b   Hertzberg, Kathe M ^a,b   Grieninger, Gerd ^a,b   Ugarova, Tatiana P ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAMBETA2 INTEGRIN; ALPHAXBETA2 INTEGRIN; ANTIBODY; CD11 ANTIGEN; CD11B ANTIGEN; CD18 ANTIGEN; COMPLEMENTARY DNA; FIBRINOGEN; FIBRINOGEN 420; INTEGRIN; LIGAND; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION;

EID: 0035889160     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V98.8.2448     Document Type: Article

References (53)

1. Languino LR, Plescia J, Duperray A, et al. Fibrinogen mediates leukocyte adhesion to vascular endothelium through an ICAM-1 -dependent pathway. Cell. 1993;73:1423-1434.
2. Languino LR, Duperray A, Joganic KJ, Fornaro M, Thornton GB, Altieri DC. Regulation of leukocyte-endothelium interaction and leukocyte transendothelial migration by intercellular adhesion molecule 1 -fibrinogen recognition. Proc Natl Acad Sci U S A. 1995;92:1505-1509.
3. Sriramarao P, Languino LR,Altieri DC. Fibrinogen mediates leukocyte-endothelium bridging in vivo at low shear forces. Blood. 1996;88:3416-3423.
4. Bini A, Fenoglio JJ Jr, Mesa-Tejada R, Kudryk B, Kaplan KL. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis: use of monoclonal antibodies. Arteriosclerosis. 1989;9:109-121.
5. Valenzuela R, Shalnoff JR, DiBelio PM, et al. Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas. Am J Pathol. 1992;141:861-880.
6. Kuijper PHM, Torres G, Lammers J-WJ, Sixma JJ, Koenderman L, Zwaginga JJ. Platelet and fibrin deposition at the damaged vessel wall: cooperative substrates for neutrophil adhesion under flow conditions, Blood. 1997;89:166-175.
7. Massberg S, Enders G, de Melo Matos FC, et al. Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemiareperfusion in vivo. Blood. 1999;94:3829-3838.
8. Colvin RB, Mosesson MW, Dvorak HF. Delayed-type hypersensitivity skin reactions in congenital afibrinogenemia lack fibrin deposition and induration. J Clin Invest. 1979;63:1302-1306.
9. McRitchie DI, Girotti MJ, Glynn MFX, Goldberg JM, Rotstein OD. Effect of systematic fibrinogen depletion on intraabdominal abscess formation. J Lab Clin Med. 1991;118:48-55.
10. Tang L, Eaton JW. Fibrin(ogen) mediates acute inflammatory responses to biomaterials. J Exp Med. 1993;178:2147-2156.
11. Wu X, Helfrich MH, Horton MA, Feigen LP, Lefkowith JB. Fibrinogen mediates platelet-polymorphonuclear leukocyte cooperation during immune-complex glomerulonephritis in rats. J Clin Invest. 1994;94:928-936.
12. Busso N, Peclat V, Van Ness K, et al. Exacerbation of antigen-induced arthritis in urokinase-deficient mice. J Clin Invest. 1998;102:41-50.
13. Altieri DC, Bader R, Mannucci PM, Edgington TS. Oligospecificity of the cellular adhesion receptor MAC-1 encompasses an inducible recognition specificity for fibrinogen. J Cell Biol. 1988;107:1893-1900.
14. Lu H, Smith CW, Perrard J, et al. LFA-1 is sufficient in mediating neutrophil emigration in Mac-1 deficient mice. J Clin Invest. 1997;99:1340-1350
15. Loike JD, Sodeik B, Cao L, et al. CD11c/CD18 on neutrophils recognizes a domain at the N terminus of the A α chain of fibrinogen. Proc Natl Acad Sci U S A. 1991;88:1044-1048.
16. Postigo AA,Corbi AL,Sanchez-Madrid F, De Landázuri MO. Regulated expression and function of CD11c/CD18 integrin on human B lymphocytes: relation between attachment to fibrinogen and triggering of proliferation through CD11c/CD18. J Exp Med. 1991;174:1313-1322.
17. Doolittle RF. Fibrinogen and fibr n. Annu Rev Biochem. 1984;53:195-229.
18. Altieri DC, Agbanyo FR, Plescia J, Ginsberg MH, Edgington TS, Plow EF. A unique recognition site mediates the interaction of fibrinogen with the leukocyte integrin Mac-1 (CD11b/CD18). J Biol Chem. 1990;265:12119-12122.
19. Medved L, Litvinovich S, Ugarova T, Matsuka Y, Ingham K. Domain structure and functional activity of the recombinant human fibrinogen γ-module (γ148-411). Biochemistry. 1997;36:4685-4693.
20. Ugarova TP, Yakubenko VP. Recognition of fibrinogen by leukocyte integrins. Ann N Y Acad Sci. 2001;936:368-386.
21. 2 (Mac-1) and promotes leukocyte adhesion. J Biol Chem. 1993;268:1847-1853.
22. 2 within the γ-chain of fibrinogen. J Biol Chem. 1998;273:22519-22527.
23. 2-mediated cell migration to fibrinogen and its recognition peptides. J Exp Med. 2001;193:1123-1134.
24. Tang L, Ugarova TP, Plow EF, Eaton JW. Molecular determinants of acute inflammatory responses to biomaterials. J Clin Invest. 1996;97:1329-1334.
25. Zhou L, Lee DH, Plescia J, Lau CY, Altieri DC. Differential ligand binding specificities of recombinant CD11b/CD18 integrin I-domain. J Biol Chem. 1994;269:17075-17079.
26. Fu Y, Grieninger G. Fib420: a normal human variant of fibrinogen with two extended α chains. Proc Natl Acad Sci U S A. 1994;91:2625-2628.
27. 420, the novel fibrinogen subclass: newborn levels are higher than adult. Blood. 1997;90:2609-2614.
28. EC domain to the structure and function of fibrinogen-420. Ann N Y Acad Sci. 2001;936:44-64.
29. Weissbach L, Grieninger G. Bipartite mRNA for chicken α-fibrinogen potentially encodes an amino acid sequence homologous to β- and γ-fibrinogens. Proc Natl Acad Scl U S A. 1990;87:5198-5202.
30. Fu Y, Weissbach L, Plant PW, et al. Carboxy-terminal-extended variant of the human fibrinogen a subunit: a novel exon conferring marked homology to β and γ subunits. Biochemistry. 1992;31:11968-11972.
31. EC domain of human fibrinogen-420 is a stable and early plasmin cleavage product. Blood. 2000;95:2297-2303.
32. Spraggon G, Everse SJ, Doolittle RF. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature. 1997;389:455-462.
33. EC domain from human fibrinogen-420. Proc Natl Acad Sci U S A. 1998;95:9099-9104.
34. Yee VC, Pratt KP, Cote HCF, et al. Crystal structure of 30 kDa carboxyl terminal fragment from the y chain of human fibrinogen. Structure. 1997;5:125-138.
35. Ugarova TP, Budzynski AZ. Interaction between complementary polymerization sites in the structural D and E domains of human fibrin. J Biol Chem. 1992;267:13687-13693.
36. EC domains of human fibrinogen 420 contain calcium binding sites but lack polymerization pockets. Blood. 1998;92:3669-3674.
37. Bolyard MG, Lord ST. High-level expression of a functional human fibrinogen γ chain in Escherichia coli. Gene. 1988;66:183-192.
38. Taubenfeld SM, Song Y, Sheng D, Ball EL, Matsueda GR. A monoclonal antibody against a peptide sequence of fibrinogen γ chain acts as an inhibitor of factor XIII-mediated crosslinking of human fibrin. Thromb Haemost. 1995;74:923-927.
39. 2. J Biol Chem. 2001;275:13995-14003.
40. Dana N, Styrt B, Griffin JD, Todd RF III, Klempner MS, Arnaout MA. Two functional domains in the phagocyte membrane glycoprotein Mo1 identified with monoclonal antibodies. J Immunol. 1986;137:3259-3263.
41. Wright SD, Rao PE, Van Voorhis WC, et al. Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies. Proc Natl Acad Sci U S A. 1983;80:5699-5703.
42. 2 integrins. J Biol Chem. 1996;271:18211-18216.
43. Miles LA, Plow EF. Receptor mediated binding of the fibrinolytic components, plasminogen and urokinase, to peripheral blood cells. Thromb Haemost. 1987;58:936-942.
44. Muchowski PJ, Zhang L, Chang ER, Soule HR, Plow EF, Moyle M. Functional interaction between the integrin antagonist neutrophil inhibitory factor and the I domain of CD11b/CD18. J Biol Chem. 1994;269:26419-26423.
45. 2 integrin CR3 (CD11b/CD18) is a receptor for the hookworm -derived neutrophil adhesion inhibitor NIF. J Cell Biol. 1994;127:2081-2091.
46. Diamond MS, Garcia-Aguilar J, Bickford JK, Corbi AL, Springer TA. The I domain is a major recognition site on the leukocyte integrin MAC-1 (CD11b/CD18) for four distinct adhesion ligands. J Cell Biol. 1993;120:1031-1043.
47. Gross TJ, Leavell KJ, Peterson MW. CD11bCD18 mediates the neutrophil chemotactic activity of fibrin degradation product D domain. Thromb Haemost. 1997;77:894-900.
48. Schwartz MA, Schaller MD, Ginsberg MH. Integrins: emerging paradigms of signal transduction. Annu Rev Cell Biol. 1995;11:549-599.
49. Perez RL, Roman J. Fibrin enhances the expression of IL-1β by human peripheral blood mononuclear cells: implications in pulmonary inflammation. J Immunol. 1995;154:1879-1887.
50. Trezzini C, Schüepp B, Maly FE, Jungi TW. Evidence that exposure to fibrinogen or to antibodies directed against Mac-1 (CDllb/CD18;CR3) modulates human monocyte effector functions. Br J Haematol. 1991;77:16-24.
51. 1 fibronectin ligands CS-1, Hep II, and RGD induce different intracellular events in B lymphoid cells: comparison with the effects of the endothelial ligand VCAM-1. Cell Adhes Commun. 1996;4:251-267.
52. 1,-mediated signaling pathways by fibronectin's cell adhesion and matrix assembly domains. J Cell Biol. 1998;141:241-253.
53. 1-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin. Exp Cell Res. 2000;260:73-84.